Show simple item record

Take control: efficacy and safety of patient-versus physician-managed titration of insulin glargine 300 u/ml (gla-300) in patients with uncontrolled type 2 diabetes

dc.contributor.authorRussell Jones, D.
dc.contributor.authorDauchy, A.
dc.contributor.authorDelgado Álvarez, Elías 
dc.contributor.authorDimitriadis, G.
dc.contributor.authorFrandsen, H. A.
dc.contributor.authorPopescu, L.
dc.contributor.authorSchultes, B.
dc.contributor.authorStrojek, K.
dc.contributor.authorBonnemaire, M.
dc.date.accessioned2018-06-07T08:57:20Z
dc.date.available2018-06-07T08:57:20Z
dc.date.issued2018
dc.identifier.citationDiabetes Technology & Therapeutics, 20(1), p. A33-A34 (2018); doi:10.1089/dia.2018.2525.abstracts
dc.identifier.issn1520-9156
dc.identifier.issn1557-8593
dc.identifier.urihttp://hdl.handle.net/10651/47377
dc.format.extentp. A33-A34
dc.language.isoeng
dc.relation.ispartofDiabetes Technology & Therapeutics, 20(1)
dc.rights© Mary Ann Liebert, Inc
dc.sourceWOS:000425015800084
dc.titleTake control: efficacy and safety of patient-versus physician-managed titration of insulin glargine 300 u/ml (gla-300) in patients with uncontrolled type 2 diabetes
dc.typeinfo:eu-repo/semantics/conferenceObject
dc.identifier.doi10.1089/dia.2018.2525.abstracts
dc.type.dcmitext
dc.relation.publisherversionhttp://dx.doi.org/10.1089/dia.2018.2525.abstracts


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record